Akero Therapeutics, Inc. AKRO
54.65 USD 0.00 0.00%
At close · Dec 9
54.69 +0.04 +0.07%
After hours · Dec 9, 4:00 PM ET
53.84 52-week range 54.83
- YTD
- +96.44%
- 1 year
- +75.67%
- Open
- 54.52
- Prev close
- 54.65
- Mkt cap
- 4.50B
- Vol
- 11.61M
- Avg vol
- 2.29M
- EPS
- -1.94
- P/E
- -29.54
- Div yield
- 0.00%
More statistics
- Low
- 54.52
- High
- 54.65
- Beta
- -0.40
- Inst. own
- 112.47%
- Dividend
- 0.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for AKRO has not been loaded yet. Try again in a moment.
Altman Z-Score
54.74 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -7.4×
P/S 0.0×
P/B 2.5×
P/FCF -8.1×
EV/EBITDA -6.3×
EV/Sales 0.0×
FCF Yield -12.4%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -33.6%
ROIC -36.3%
ROA -30.5%
Revenue 0.0%
Operating Income -65.1%
EPS (diluted) -29.8%
Free Cash Flow -59.0%
Current Ratio 19.4×
Quick Ratio 19.4×
Debt / Equity 0.0×
Net Debt / EBITDA 1.2×
Interest Coverage -61.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2024-12-31